CN Patent

CN106278999A — S1p调节剂

Assigned to Than Ao Gen Ma Co · Expires 2017-01-04 · 9y expired

What this patent protects

本发明涉及作为S1P调节剂的化合物以及制备及使用所述化合物的方法，及其药物组合物。具体地，所述化合物为式(I)化合物，其可调节S1P受体的活性。本发明还涉及式(I)化合物或其药学上可接受的盐在制备用于预防或治疗哺乳动物的涉及S1P受体活性的病理性病症或症状的药物中的用途。

USPTO Abstract

本发明涉及作为S1P调节剂的化合物以及制备及使用所述化合物的方法，及其药物组合物。具体地，所述化合物为式(I)化合物，其可调节S1P受体的活性。本发明还涉及式(I)化合物或其药学上可接受的盐在制备用于预防或治疗哺乳动物的涉及S1P受体活性的病理性病症或症状的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN106278999A
Jurisdiction
CN
Classification
—
Expires
2017-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Than Ao Gen Ma Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.